Clinical epidemiology of snakebite envenoming in hospitals 11 provinces of Yangtze River Basin and southern regions of China: A retrospective hospital-based analysis
Authors:
Open Access
- 27 April 2026
- journal article
- research article
- Published by Public Library of Science (PLoS) in PLOS Neglected Tropical Diseases
- Vol. 20 (4) , e0013247
Abstract
Background: As the largest developing country, China works towards reducing mortality and disability from snakebite envenoming (SBE) by 50% before 2030, as epidemiological evidences are essential. Methods: A cross-sectional survey was conducted in 11 provinces in China using a multistage stratified cluster random sampling, and hospitalized snakebite victims with complete case histories from January 1, 2017, to December 31, 2021, were included. Results: A total of 40,817 snakebite victims were enrolled in this study. The most common snake species were Agkistrodon halys (16.04%) and Trimeresurus stejnegeri (11.40%). However, 56.36% of the snake species remained unidentified. Furthermore, our results revealed that 60.36% of snakebite victims were males, 63.71% were older than 50 years, 59.70% were peasants, 11.14% experienced moderate envenomation on admission, and 0.64% had severe envenomation on admission. Ultimately, only 6.82% of the victims achieved complete healing, whereas 82.44% of snakebite victims demonstrated improvement in their condition upon discharge. Only 69.57% of snakebite victims received antivenom treatments. Furthermore, age, occupation, hospitalization duration, snake specie, site of bite, location, activity, envenomation on admission, clinical manifestation, and treatment significantly affected the discharge outcomes of snakebite victims. Conclusions: This study is the first large-sample investigation focusing on the epidemiological characteristics of SBE in China, addressing research gaps and filling the void in the relevant the World Health Organization data. The findings call for authorities and managers to strengthen partnerships, coordination, and resources, reduce SBE incidents, and ensure that victims receive fair, safe, and effective treatments.Keywords
Funding Information
- Hainan Province Science and Technology Special Fund (ZDKJ202004)
- Hainan Province Science and Technology Special Fund (ZDKJ2021038)
- Hainan Provincial Natural Science Foundation of China (821RC557)
- National Natural Science Foundation of China (82160647)
- Finance Science and Technology Program of Sichuan Province (2022YFS0602)
- Hainan Clinical Medical Research Center Project (LCYX202310)
This publication has 36 references indexed in Scilit:
- Does Covid-19 influence the dynamics of envenomation by animals in a country strongly affected by both conditions? Epidemiological data from BrazilToxicon, 2024
- Snakebite care through the first two waves of COVID-19 in West Bengal, India: a qualitative studyToxicon: X, 2023
- Clinical aspects of snakebite envenoming and its treatment in low-resource settingsThe Lancet, 2023
- Snakebite knowledge assessment and training of healthcare professionals in Asia, Africa, and the Middle East: A reviewToxicon: X, 2022
- Adverse reactions to four types of monovalent antivenom used in the treatment of snakebite envenoming in South ChinaToxicon, 2022
- Access to antivenoms in the developing world: A multidisciplinary analysisToxicon: X, 2021
- The Epidemiology, Clinical Course, and Management of Snakebites in the North American Snakebite RegistryJournal of Medical Toxicology, 2017
- Detecting and Attributing the Effects of Climate Change on the Distributions of Snake Species Over the Past 50 YearsEnvironmental Management, 2015
- Clinical features and treatment experience: A review of 292 Chinese cobra snakebitesEnvironmental Toxicology and Pharmacology, 2014
- Estimate of the burden of snakebites in sub-Saharan Africa: A meta-analytic approachToxicon, 2011